Search
forResearch 10 of 1000+
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Trailing the Path to Preventive Oncology
- TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine
- Tailoring bioinks of extrusion-based bioprinting for cutaneous wound healing
- A Splice Site Mutation in the Gene of the Human Type I Hair Keratin hHa1 Results in the Expression of a Tailless Keratin Isoform
- Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route
- High-resolution stable isotope profiles of modern elephant (Loxodonta africana) tusk dentin and tail hair from Kenya: Implications for identifying seasonal variability in climate, ecology, and diet in ancient proboscideans
- Tailored chromatin modulation to promote tissue regeneration
- Tail Tales: What We Have Learned About Regeneration from Xenopus Laevis Tadpoles
- The high-polarity fraction of tail fat derived from Lanzhou Fat-Tailed sheep enhances skin wound healing through the regulation of inflammatory factors and the TGF-β1/Smad3 signaling pathway
Community 10 of 307
- Trialing the probiotics BB536, PTA 6475 so you don’t have to
- Train your forehead and scalp muscles
- Trial for TDM-105795 update from research office
- Recent trials investigating mesenchymal stem cell derived exosomes demonstrate significant increases in anagen duration and hair shaft caliber by upregulating Wnt/beta-catenin pathways.
- Evidence of DUT shedding in clinical trials?
- ABS-201 Trial - What should I know going in
- $20,000 reimbursement to participate in a Hair Loss Clinical Trial (in Australia) that could grow back your hair and reverse grey hair if successful.
- Pp405 trials question - 2a/2b,
- Cure For Baldness And Thinning Hair in 2A Clinical Trials
- Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy